glp 1 and naion GLP-1 RAs NAION: No increased risk in large US study | Paramesh Shamanna posted on the topic Breaking Med
Description
While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments

GLP-1 use linked to fewer headaches in idiopathic intracranial hypertension Idiopathic intracranial hypertension is prevalent among young women with obesity

Just one grab-and-go snack pack of gummies daily
da Silva Junior ALS, Nascimento MM, Santos HM, Lbo IP, de Oliveira RA, de Jesus RM
Physician-supervised GLP-1 weight loss injections in Columbus, GA

PlexusDx Precision Peptide Genetic Testing identifies your peptide pathways to optimize treatment outcomes